Blood test may predict who needs a breathing tube

NCT ID NCT07607080

Recruiting now Knowledge-focused Sponsor: Hospital del Mar Research Institute (IMIM) Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study with 300 ICU patients aims to see if combining blood markers (metabolomics) with standard clinical data can better predict when high-flow nasal cannula fails, requiring a breathing tube. Researchers will collect blood samples and monitor outcomes to build a predictive model. The goal is to personalize respiratory support and avoid delays in escalation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a tool that helps doctors predict which patients need more intensive breathing support, potentially improving outcomes.
What could go wrong: This is an early observational study, not a treatment trial. The findings may not lead to immediate changes in care, and the predictive model might not be accurate enough for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HYPOXEMIC RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE HYPOXEMIC RESPIRATORY FAILURE

Contacts and locations

Locations

Hospital del Mar
RECRUITING

Barcelona, Catalonia, 08003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.